Abstract
Purpose
To report the characteristics and genetic epidemiology of keratoconus patients in the Korean population based on questionnaires, ophthalmologic findings, and genetic studies.
Methods
From September 2007 through August 2009, an epidemiologic investigation was performed through questionnaires and ocular examination of 190 keratoconus patients. To investigate the genetic cause, blood samples were taken from the keratoconus patients. Genetic analysis of keratoconus was performed through the analysis of sensitive candidate genes.
Results
The mean age of the study subjects was 29.6 years. Seventy-seven percent of the subjects rubbed their eyes with 17 percent suffering from atopy, allergy, and asthma. Thirty-two percent of subjects demonstrated Vogt's striae as the most frequent biomicroscopic keratoconus finding. No family history was found. Genetic analysis showed sensitive genetic variations of VSX1, LUM, and IL1B.
Figures and Tables
References
1. Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol. 1984. 28:293–322.
2. Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998. 42:297–319.
3. Bron AJ. Keratoconus. Cornea. 1988. 7:163–169.
4. Cristina Kenney M, Brown DJ. The cascade hypothesis of keratoconus. Cont Lens Anterior Eye. 2003. 26:139–146.
5. Bawazeer AM, Hodge WG, Lorimer B. Atopy and keratoconus:a multivariate analysis. Br J Ophthalmol. 2000. 84:834–836.
6. Macsai MS, Varley GA, Krachmer JH. Development of keratoconus after contact lens wear. Arch Ophthalmol. 1990. 108:534–538.
7. Brown D, Chwa MM, Opbroek A, Kenney MC. Keratoconus corneas: increased gelatinolytic activity appears after modification of inhibitors. Curr Eye Res. 1993. 12:571–581.
8. Sawaguchi S, Twining SS, Yue BY, et al. Alpha-1 proteinase inhibitor levels in keratoconus. Exp Eye Res. 1990. 50:549–554.
9. Opbroek A, Kenney MC, Brown D. Characterization of a human corneal metalloproteinase inhibitor (TIMP-1). Curr Eye Res. 1993. 12:877–883.
10. Zhou L, Sawaguchi S, Twining SS, et al. Expression of degradative enzymes and protease inhibitors in corneas with keratoconus. Invest Ophthalmol Vis Sci. 1998. 39:1117–1124.
11. Buddi R, Lin B, Atilano SR, et al. Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem. 2002. 50:341–351.
12. Kim WJ, Rabinowitz YS, Meisler DM, Wilson SE. Keratocyte apoptosis associated with keratoconus. Exp Eye Res. 1999. 69:475–481.
13. Wilson SE, Kim WJ. Keratocyte apoptosis: implications on corneal wound healing, tissue organization, and disease. Invest Ophthalmol Vis Sci. 1998. 39:220–226.
14. Hosseini SM, Herd S, Vincent AL, Héon E. Genetic analysis of chromosome 20-related posterior polymorphous corneal dystrophy: genetic heterogeneity and exclusion of three candidate genes. Mol Vis. 2008. 14:71–80.
15. Li X, Rabinowitz YS, Tang YG, et al. Two-stage genome-wide linkage scan in keratoconus sib pair families. Invest Ophthalmol Vis Sci. 2006. 47:3791–3795.
16. Dash DP, Silvestri G, Hughes AE. Fine mapping of the keratoconus with cataract locus on chromosome 15q and candidate gene analysis. Mol Vis. 2006. 12:499–505.
17. Tang YG, Rabinowitz YS, Taylor KD, et al. Genomewide linkage scan in a multigeneration Caucasian pedigree identifies a novel locus for keratoconus on chromosome 5q14.3-q21.1. Genet Med. 2005. 7:397–405.
18. Hughes AE, Dash DP, Jackson AJ, et al. Familial keratoconus with cataract: linkage to the long arm of chromosome 15 and exclusion of candidate genes. Invest Ophthalmol Vis Sci. 2003. 44:5063–5066.
19. Tyynismaa H, Sistonen P, Tuupanen S, et al. A locus for autosomal dominant keratoconus: linkage to 16q22.3-q23.1 in Finnish families. Invest Ophthalmol Vis Sci. 2002. 43:3160–3164.
20. Bisceglia L, Ciaschetti M, De Bonis P, et al. VSX1 mutational analysis in a series of Italian patients affected by keratoconus: detection of a novel mutation. Invest Ophthalmol Vis Sci. 2005. 46:39–45.
21. Steinkasserer A, Spurr NK, Cox S, et al. The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci. Genomics. 1992. 13:654–657.
22. Timms AE, Crane AM, Sims AM, et al. The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis. Am J Hum Genet. 2004. 75:587–595.
23. Cantagrel A, Navaux F, Loubet-Lescoulié P, et al. Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum. 1999. 42:1093–1100.
24. Udar N, Atilano SR, Small K, et al. SOD1 haplotypes in familial keratoconus. Cornea. 2009. 28:902–907.
25. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005. 21:263–265.
26. Choi SH, Lee YW, Kim HM, et al. Epidemiologic studies of keratoplasty in Korea. J Korean Ophthalmol Soc. 2006. 47:538–547.
27. Uhm SL, Chung SK, Myung YW, Rhee SW. Clinical analysis of keratoplasty over a 23 year-time span. J Korean Ophthalmol Soc. 1991. 32:421–429.
28. Doh HJ, Kim KB, Joo CK. The clinical feature of keratoconus in Korean. J Korean Ophthalmol Soc. 2000. 41:1509–1514.
29. Zadnik K, Barr JT, Gordon MO, Edrington TB. Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study Group. Biomicroscopic signs and disease severity in keratoconus. Cornea. 1996. 15:139–146.
30. Lass JH, Lembach RG, Park SB, et al. Clinical management of keratoconus. A multicenter analysis. Ophthalmology. 1990. 97:433–445.
31. Ertan A, Muftuoglu O. Keratoconus clinical findings according to different age and gender groups. Cornea. 2008. 27:1109–1113.
32. Owens H, Gamble G. A profile of keratoconus in New Zealand. Cornea. 2003. 22:122–125.
33. Zadnik K, Barr JT, Edrington TB, et al. Baseline findings in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. Invest Ophthalmol Vis Sci. 1998. 39:2537–2546.
34. Lee LR, Readshaw G, Hirst LW. Keratoconus: the clinical experience of a Brisbane ophthalmologist. Ophthalmic Epidemiol. 1996. 3:119–125.
35. Swann PG, Waldron HE. Keratoconus: the clinical spectrum. J Am Optom Assoc. 1986. 57:204–209.
36. Tuft SJ, Moodaley LC, Gregory WM, et al. Prognostic factors for the progression of keratoconus. Ophthalmology. 1994. 101:439–447.
37. Kennedy RH, Bourne WM, Dyer JA. A 48-year clinical and epidemiologic study of keratoconus. Am J Ophthalmol. 1986. 101:267–273.
38. Ihalainen A. Clinical and epidemiological features of keratoconus genetic and external factors in the pathogenesis of the disease. Acta Ophthalmol Suppl. 1986. 178:1–64.
39. Eran P, Almogit A, David Z, et al. The D144E substitution in the VSX1 gene: a non-pathogenic variant or a disease causing mutation? Ophthalmic Genet. 2008. 29:53–59.
40. Tang YG, Picornell Y, Su X, et al. Three VSX1 gene mutations, L159M, R166W, and H244R, are not associated with keratoconus. Cornea. 2008. 27:189–192.
41. Liskova P, Ebenezer ND, Hysi PG, et al. Molecular analysis of the VSX1 gene in familial keratoconus. Mol Vis. 2007. 13:1887–1891.
42. Barbaro V, Di Iorio E, Ferrari S, et al. Expression of VSX1 in human corneal keratocytes during differentiation into myofibroblasts in response to wound healing. Invest Ophthalmol Vis Sci. 2006. 47:5243–5250.
43. Lee JE, Oum BS, Lee JS. Identified differentially expressed genes in keratoconus. J Korean Ophthalmol Soc. 2006. 47:2012–2019.
44. Stabuc-Silih M, Strazisar M, Ravnik-Glavac M, et al. Genetics and clinical characteristics of keratoconus. Acta Dermatovenerol Alp Panonica Adriat. 2010. 19:3–10.
45. Udar N, Atilano SR, Brown DJ, et al. SOD1: a candidate gene for keratoconus. Invest Ophthalmol Vis Sci. 2006. 47:3345–3351.
46. Udar N, Atilano SR, Small K, et al. SOD1 haplotypes in familial keratoconus. Cornea. 2009. 28:902–907.
47. Stabuc-Silih M, Strazisar M, Hawlina M, Glavac D. Absence of pathogenic mutations in VSX1 and SOD1 genes in patients with keratoconus. Cornea. 2010. 29:172–176.